1,711
Participants
Start Date
June 30, 2004
Primary Completion Date
April 30, 2006
Study Completion Date
April 30, 2006
Ibandronate
Film-coated oral ibandronate tablet (150 mg) once-monthly
New York
Brooklyn
East Syracuse
Rochester
Olean
Bala-Cynwyd
Langhorne
Philadelphia
Philadelphia
Wyomissing
Wilmington
Bethesda
Baltimore
Richmond
Richmond
Norfolk
Winston-Salem
Raleigh
Durham
Durham
Salisbury
Fayetteville
Wilmington
Morehead City
Morganton
Spartanburg
Charleston
Mt. Pleasant
Decatur
Rome
Atlanta
Augusta
Port Orange
Gainesville
Gainesville
DeLand
Longwood
Melbourne
Palm Bay
Aventura
Miami
West Palm Beach
Clearwater
Fort Myers
Sarasota
Ocala
Palm Harbor
Columbiana
Birmingham
Huntsville
Montgomery
Mobile
Murfreesboro
Nashville
Bristol
Sevierville
Memphis
Columbus
Beachwood
Canfield
Cincinnati
Evansville
Chelsea
Detroit
Saint Joseph
Milwaukee
Madison
Chaska
Fargo
Grand Forks
Billings
Creve Coeur
Peoria
Champaign
St Louis
St Louis
St Louis
St Louis
Kansas City
Kansas City
Jefferson City
Arkansas City
Newton
Wichita
Omaha
New Orleans
Natchitoches
Pine Bluff
Carlisle
Sherwood
Searcy
Little Rock
Jonesboro
Rogers
Oklahoma City
Tulsa
Carrollton
Dallas
Denton
Wichita Falls
San Antonio
Corpus Christi
Lakewood
Colorado Springs
Boise
Coeur d'Alene
Phoenix
Phoenix
Chandler
Paradise Valley
Tempe
Gilbert
Tucson
Beverly Hills
Westlake Village
Vista
San Diego
Palm Desert
Laguna Hills
Mission Viejo
Anaheim
Palo Alto
Sacramento
Portland
Medford
Renton
Seattle
Seattle
Tacoma
Tacoma
Spokane
Avon
Cromwell
Hamden
New London
Waterbury
Clifton
Middletown
New Brunswick
Princeton
Stony Brook
Norfolk
Hoffmann-La Roche
INDUSTRY